{
    "title": "AstraZeneca COVID-19 shot candidate shows promise among elderly in trials",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8965027/AstraZeneca-COVID-19-shot-candidate-shows-promise-elderly-trials.html",
    "date": "2020-11-19",
    "keywords": [
        "vaccine",
        "covid19",
        "disease",
        "latestage",
        "kate",
        "kelland",
        "oxford",
        "risk",
        "health",
        "phase",
        "infection",
        "sarscov2",
        "efficacy",
        "plc",
        "university",
        "response",
        "hope",
        "midstage",
        "part",
        "month",
        "journal",
        "illness",
        "death",
        "immunity",
        "antibody",
        "tcell",
        "study",
        "consultant",
        "investigator",
        "group",
        "society",
        "research",
        "range",
        "report",
        "candidate",
        "azd1222",
        "chadox1",
        "coronavirus",
        "biontech",
        "moderna",
        "pfizerbiontech",
        "technology",
        "messenger",
        "rna",
        "shot",
        "vector",
        "version",
        "cold",
        "virus",
        "ii",
        "trial",
        "lancet",
        "total",
        "placebo",
        "side",
        "astrazeneca",
        "supply",
        "manufacturing",
        "world",
        "editing",
        "matthew",
        "lewis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}